AstraZeneca's COPD candidate succeeds in twin Phase III studies
27th Mar 2026 07:07
(Sharecast News) - Drugmaker AstraZeneca said on Friday that its monoclonal antibody tozorakimab had met the primary endpoint in both of its Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease.
Read moreAstraZeneca's Calquence leukaemia treatment gets US FDA approval
20th Feb 2026 10:40
(Sharecast News) - AstraZeneca said on Friday that the US Food and Drug Administration has approved its 'Calquence', or acalabrutinib, in combination with venetoclax as the first all-oral, fixed-duration regimen for the treatment of adult patients with chronic lymphocytic leukaemia and small lymphocytic lymphoma in the first-line setting.
Read moreShore Capital lowers AstraZeneca to 'hold'
13th Feb 2026 13:59
(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings outlook looked less favourable despite what it called "exceptional" R&D delivery.
Read moreAnnual sales, profits jump at AstraZeneca
10th Feb 2026 07:29
(Sharecast News) - AstraZeneca posted a spike in full-year revenues and earnings on Tuesday, boosted by strong demand for its cancer drugs, and forecast further growth in the current year.
Read moreFDA rejects self-injectable version of AstraZeneca lupus drug
3rd Feb 2026 07:34
(Sharecast News) - The US health regulator has rejected an application by AstraZeneca to launch a self-injectable version of its lupus treatment Saphnelo, the drugs giant confirmed on Tuesday.
Read moreAstrazeneca's Imfinzi receives EU recommendation from CHMP
2nd Feb 2026 07:29
(Sharecast News) - Drugmaker Astrazeneca said on Monday that its gastric and gastroesophageal junction cancer treatment, Imfinzi, has been recommended for approval in the European Union by the Committee for Medicinal Products for Human Use (CHMP).
Read moreAstraZeneca strikes collaborative agreement with CSPC Pharmaceuticals
30th Jan 2026 07:03
(Sharecast News) - Drugmaker Astrazeneca said on Friday that it has expanded its weight‑management pipeline after striking a strategic collaboration with CSPC Pharmaceuticals to develop a series of next‑generation obesity and type‑2 diabetes therapies.
Read moreAstraZeneca unveils $15bn China investment
29th Jan 2026 07:37
(Sharecast News) - AstraZeneca is to invest $15bn in China by the end of the decade, the UK drugs giant confirmed on Thursday, as part of the prime minister's visit to the country.
Read moreCiti starts AstraZeneca at 'buy', takes 'neutral' stance on GSK
27th Jan 2026 11:36
(Sharecast News) - Analysts at Citi initiated coverage of AstraZeneca and GSK on Tuesday, taking a bullish stance on the former but a more cautious view on the latter.
Read moreAstraZeneca chalks up dual regulatory wins in cancer and immunology
16th Dec 2025 07:42
(Sharecast News) - Drugmaker AstraZeneca chalked up two regulatory wins on Tuesday, with approvals in both the US and Europe for key treatments in oncology and immunology.
Read moreAstraZeneca secures US approval for Imfinzi in gastric cancer
26th Nov 2025 07:03
(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that its Imfinzi asset has been approved in the US for use alongside standard FLOT chemotherapy in the treatment of adult patients with resectable, early‑stage and locally advanced gastric and gastroesophageal junction cancers.
Read moreAstraZeneca to spend $2bn in US manufacturing push
24th Nov 2025 07:01
(Sharecast News) - AstraZeneca is to invest $2bn ramping up manufacturing facilities in Maryland, America, the blue chip drugs giant said on Monday.
Read moreAstraZeneca receives FDA approval for expanded Koselugo usage
20th Nov 2025 07:12
(Sharecast News) - The US Food and Drug Administration has approved the expanded usage of AstraZeneca's Koselugo drug to adults with neurofibromatosis type 1 (NF1) - a rare, progressive, genetic condition that can impact every organ system.
Read moreDirector dealings: 3i execs buy the dip, AstraZeneca CFO offloads shares
14th Nov 2025 13:53
(Sharecast News) - London-listed companies 3i Group and AstraZeneca disclosed fresh director dealings on Wednesday, with senior executives at the private equity group adding to their holdings while AstraZeneca's finance chief sold American Depositary Shares.
Read moreAstraZeneca beats Q3 expectations, maintains FY outlook
6th Nov 2025 09:18
(Sharecast News) - Drugmaker AstraZeneca reiterated its full-year guidance on Thursday as it posted a third-quarter earnings beat, driven by solid sales of its cancer, heart and kidney disease drugs.
Read more